PRKAR1B-related neurodegenerative dementia with intermediate filaments
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
PRKAR1B mutation associated with a new neurodegenerative disorder with unique pathology.
|
24722252 |
2014 |
PRKAR1B-related neurodegenerative dementia with intermediate filaments
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutation frequency of PRKAR1B and the major familial dementia genes in a Dutch early onset dementia cohort.
|
25108559 |
2014 |
Frontotemporal dementia
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
No pathogenic PRKAR1B mutations were found in the early onset AD and FTD patients of our study.
|
25108559 |
2014 |
Frontotemporal dementia
|
0.120 |
Biomarker
|
disease |
BEFREE |
Screening of PRKAR1B in 138 patients with Parkinson's disease and 56 patients with frontotemporal dementia did not identify additional novel pathogenic mutations.
|
24722252 |
2014 |
Frontotemporal dementia
|
0.120 |
Biomarker
|
disease |
HPO |
|
|
|
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Red Blood Cell Count measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Amino acids measurement
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Genetic basis for plasma amino acid concentrations based on absolute quantification: a genome-wide association study in the Japanese population.
|
30659259 |
2019 |
Histidine measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic basis for plasma amino acid concentrations based on absolute quantification: a genome-wide association study in the Japanese population.
|
30659259 |
2019 |
Tryptophan measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic basis for plasma amino acid concentrations based on absolute quantification: a genome-wide association study in the Japanese population.
|
30659259 |
2019 |
Varicosity
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Clinical and Genetic Determinants of Varicose Veins.
|
30566020 |
2018 |
Red Blood Cell Count measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
Hematocrit procedure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
Hemoglobin measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
Accidental Falls
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Anxiety
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Ciliary Motility Disorders
|
0.100 |
CausalMutation
|
group |
CLINVAR |
|
|
|
Language Disorders
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Apathy
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Muscular stiffness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Inappropriate behavior
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Bradykinesia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Memory impairment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Parkinsonian Disorders
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Reduced concentration span
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|